CSPC Pharmaceutical Group Limited (CVG) — Cash Flow Reinvestment Rate

Latest as of September 2020: 0.39x

CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow Reinvestment Rate of 0.39x as of September 2020, reinvesting €831.32 Million (capex €258.14 Million plus investments €-573.18 Million) from operating cash flow of €2.16 Billion. Check CVG operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.39x
(Capex + Investments) / Operating CF

Total Reinvested

€831.32 Million
Capex + Investments

Operating Cash Flow

€2.16 Billion
EUR

Capital Expenditures

€258.14 Million
EUR

CSPC Pharmaceutical Group Limited Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for CSPC Pharmaceutical Group Limited across 13 annual periods. Explore CSPC Pharmaceutical Group Limited (CVG) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for CSPC Pharmaceutical Group Limited (2013–2025)

Year-by-year capital reinvestment analysis for CSPC Pharmaceutical Group Limited. For live market cap and broader valuation context, see market value of CSPC Pharmaceutical Group Limited.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.74x €4.33 Billion €5.83 Billion €2.28 Billion ▼ -18.3%
2024 0.91x €4.12 Billion €4.53 Billion €2.68 Billion ▲ +51.9%
2023 0.60x €2.50 Billion €4.18 Billion €1.89 Billion ▼ -27.5%
2022 0.83x €6.30 Billion €7.63 Billion €2.22 Billion ▲ +87.5%
2021 0.44x €2.04 Billion €4.64 Billion €1.41 Billion ▲ +64.2%
2020 0.27x €1.81 Billion €6.74 Billion €1.36 Billion ▼ -52.7%
2019 0.57x €2.14 Billion €3.78 Billion €1.88 Billion ▼ -30.7%
2018 0.82x €3.10 Billion €3.80 Billion €1.67 Billion ▼ -7.3%
2017 0.88x €2.90 Billion €3.29 Billion €1.18 Billion ▲ +14.0%
2016 0.77x €2.25 Billion €2.92 Billion €1.06 Billion ▲ +101.0%
2015 0.38x €864.81 Million €2.25 Billion €815.69 Million ▼ -15.4%
2014 0.45x €820.58 Million €1.81 Billion €807.00 Million ▼ -40.6%
2013 0.77x €623.39 Million €814.86 Million €597.12 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow